Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3451
VerifyMe
VRME
$10.6M
| $36K | ﹤0.01% |
30,849
-15,351
| -33% | -$17.9K |
|
3452
Biodesix
BDSX
$58.2M
| $35K | ﹤0.01% |
21,400
-12,700
| -37% | -$20.8K |
|
3453
Paramount Gold Nevada
PZG
$72.9M
| $35K | ﹤0.01% |
124,300
-25,100
| -17% | -$7.07K |
|
3454
US Energy Corp
USEG
$38.8M
| $35K | ﹤0.01% |
25,700
+4,300
| +20% | +$5.86K |
|
|
MRDB
3455
DELISTED
MariaDB plc
MRDB
| $35K | ﹤0.01% |
73,552
+9,123
| +14% | +$4.34K |
|
|
IH
3456
iHuman
IH
$154M
| $34K | ﹤0.01% |
11,125
-3,735
| -25% | -$11.4K |
|
3457
IO Biotech
IOBT
$125M
| $34K | ﹤0.01% |
24,386
-44,714
| -65% | -$62.3K |
|
3458
Performance Shipping
PSHG
$23.5M
| $34K | ﹤0.01% |
+17,502
| New | +$34K |
|
3459
Rezolute
RZLT
$698M
| $34K | ﹤0.01% |
25,700
+3,800
| +17% | +$5.03K |
|
3460
Anixa Biosciences
ANIX
$96.3M
| $33K | ﹤0.01% |
10,000
-49,300
| -83% | -$163K |
|
|
EMX
3461
EMX Royalty
EMX
$454M
| $33K | ﹤0.01% |
18,569
-225,557
| -92% | -$401K |
|
3462
Arq
ARQ
$302M
| $32K | ﹤0.01% |
17,845
-62,554
| -78% | -$112K |
|
3463
Golden Matrix Group
GMGI
$148M
| $31K | ﹤0.01% |
+10,500
| New | +$31K |
|
3464
IGC Pharma
IGC
$35.3M
| $31K | ﹤0.01% |
86,902
-75,807
| -47% | -$27K |
|
3465
Koss Corp
KOSS
$54.5M
| $31K | ﹤0.01% |
+10,600
| New | +$31K |
|
|
NXXT
3466
NextNRG, Inc. Common Stock
NXXT
$243M
| $31K | ﹤0.01% |
4,682
-280
| -6% | -$1.85K |
|
|
CZOO
3467
DELISTED
Cazoo Group Ltd
CZOO
| $31K | ﹤0.01% |
575
+34
| +6% | +$1.83K |
|
3468
Allied Gaming & Entertainment
AGAE
$34.6M
| $30K | ﹤0.01% |
33,400
+1,700
| +5% | +$1.53K |
|
|
INCR
3469
Intercure
INCR
$87.2M
| $30K | ﹤0.01% |
18,800
+7,600
| +68% | +$12.1K |
|
|
OKYO
3470
OKYO Pharma
OKYO
$83.9M
| $30K | ﹤0.01% |
+16,347
| New | +$30K |
|
3471
Phio Pharmaceuticals
PHIO
$13.7M
| $30K | ﹤0.01% |
2,190
+937
| +75% | +$12.8K |
|
|
TC
3472
TuanChe
TC
$28.8M
| $30K | ﹤0.01% |
191
-3
| -2% | -$471 |
|
3473
Knightscope
KSCP
$59.1M
| $29K | ﹤0.01% |
+742
| New | +$29K |
|
3474
Theriva Biologics
TOVX
$4.13M
| $29K | ﹤0.01% |
2,168
+620
| +40% | +$8.29K |
|
|
RNTX
3475
Rein Therapeutics, Inc. Common Stock
RNTX
$27.8M
| $29K | ﹤0.01% |
18,964
+3,100
| +20% | +$4.74K |
|